Active-ingredient Dossier
Latanoprost
Active-ingredient Dossier for Latanoprost (prostaglandin analogue). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: XALATAN
- Brand: APOTEX-Latanoprost/Timolol
- Brand: APO-LATANOPROST
- Brand: APO-Latanoprost/Timolol
- Brand: LATANOPROST
- Brand: LATANOPROST-WGR
- Therapeutic area: Ophthalmology
What is
Latanoprost Latanoprost is a prostaglandin analogue.
Australian brands containing
Latanoprost — XALATAN — APOTEX-Latanoprost/Timolol — APO-LATANOPROST — APO-Latanoprost/Timolol — LATANOPROST — LATANOPROST-WGR — XALACOM — XALAMOL — XALAPROST
Therapeutic areas
Latanoprost is registered in ophthalmology, with 19 brands containing this ingredient on the ARTG.
Sponsor landscape
The ingredient is marketed by six sponsors: Arrotex Pharmaceuticals, Aspen Pharmacare, GM Pharma, Viatris, Cipla, and Sandoz.
PBS and regulatory activity
One brand containing latanoprost has PBS-listed items, with the latest PBS schedule date of 1 May 2026. In the 2013–14 fiscal year, latanoprost generated government expenditure of AUD 36.8 million across 1.3 million prescriptions. The latest PBAC outcome is from November 2005, with one brand holding a PBAC outcome on record and no brands with AusPARs on record.